President Biden Signs Spending Bill, Boosting NIH, CDC, and FDA Budgets

President Joe Biden signed into law a $1.65 trillion spending bill that, in addition to averting a government shutdown, increases the budgets of the US Food and Drug Administration, National Institutes of Health, and the Centers for Disease Control and Prevention.

Under the bill, the FDA receives $3.5 billion in discretionary funding, representing a $226 million year-over-year increase and bringing total funding, including revenue from user fees, to $6.6 billion.

The bill provides $47.5 billion for the NIH, a year-over-year increase of $2.5 billion. Funding includes $7.3 billion for the National Cancer Institute, including $216 million for the NCI component of the Cancer Moonshot; $3.7 billion for research into Alzheimer’s disease and other dementias; $75 million for expanded access and activities authorized in the ACT for ALS Act; $57 million in expanded support for minority-serving institutions and health disparities research; $3.3 billion for HIV/AIDS research; and $270 million for universal flu vaccine research, among others.

Source: https://www.genomeweb.com/research-funding/president-biden-signs-spending-bill-boosting-nih-cdc-and-fda-budgets#.Y7Qrx3bMKUk